AAP News Vol. 13 No. 9 September 1997, p. 15
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davoli, E.
Right arrow Search for Related Content

 Previous Article  |  Next Article 

ITALY

Enrico Davoli M.D., FAAP

The first international CME course, a historical, collaborative venture between the Academy and the Società Italiana di Pedliatria (SIP) took place June 15-20. Three of the countries major academic centers — Bologna, Pavia and Padova (Padua) — served as course venues, representing the three oldest universities and main centers of medical teaching and learning, dating to before the Renaisance.

With an audience of Italian American physicians, day one of scientific sessions began in Bologna With a comparison and discussion of the respective health care systems. Simultaneous translation facilitated an uninterrupted continuity of thought and complete understanding of issues throughout the program.

During the hematology-oncology session, we learned of Italy's comprehensive network for pediatric cancer care and research, as well as issues concerning iron-deficiency anemia in the United States and the management of cerebral tumors and neuroblastoma in Italy.

A discussion of computer-based pediatric resources included an overview of Pediatric electronic pages, by Jerold Lucey, M.D., editor of Pediatrics. Italian physicians demonstrated their national computer network, CINECA, and reported on the development of primary care office-based data retrieval, as well as software for surveillance of adverse drug reactions and efficacy of specific drug therapies.